GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Current Deferred Revenue

PCL (XKRX:241820) Current Deferred Revenue : ₩0 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PCL Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

PCL's current deferred revenue for the quarter that ended in Jun. 2024 was ₩0 Mil.

PCL Current Deferred Revenue Historical Data

The historical data trend for PCL's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Current Deferred Revenue Chart

PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PCL Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PCL Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of PCL's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PCL Business Description

Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL Headlines

No Headlines